Document Detail

Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood.
MedLine Citation:
PMID:  21519036     Owner:  NLM     Status:  Publisher    
BACKGROUND: Massively parallel DNA sequencing of cell-free fetal DNA from maternal blood can detect fetal chromosomal abnormalities. Although existing algorithms focus on the detection of fetal trisomy 21 (T21), these same algorithms have difficulty detecting trisomy 18 (T18). METHODS: Blood samples were collected from 1014 patients at 13 US clinic locations before they underwent an invasive prenatal procedure. All samples were processed to plasma, and the DNA extracted from 119 samples underwent massively parallel DNA sequencing. Fifty-three sequenced samples came from women with an abnormal fetal karyotype. To minimize the intra- and interrun sequencing variation, we developed an optimized algorithm by using normalized chromosome values (NCVs) from the sequencing data on a training set of 71 samples with 26 abnormal karyotypes. The classification process was then evaluated on an independent test set of 48 samples with 27 abnormal karyotypes. RESULTS: Mapped sites for chromosomes of interest in the sequencing data from the training set were normalized individually by calculating the ratio of the number of sites on the specified chromosome to the number of sites observed on an optimized normalizing chromosome (or chromosome set). Threshold values for trisomy or sex chromosome classification were then established for all chromosomes of interest, and a classification schema was defined. Sequencing of the independent test set led to 100% correct classification of T21 (13 of 13) and T18 (8 of 8) samples. Other chromosomal abnormalities were also identified. CONCLUSION: Massively parallel sequencing is capable of detecting multiple fetal chromosomal abnormalities from maternal plasma when an optimized algorithm is used.
Amy J Sehnert; Brian Rhees; David Comstock; Eileen de Feo; Gabrielle Heilek; John Burke; Richard P Rava
Related Documents :
21484996 - Familial ring (18) mosaicism in a 23-year-old young adult with 46,xy,r(18) (::p11→q21::...
21552946 - Allele loss in human gastric carcinomas - relation to tumor progression and differentia...
12533816 - Pitfalls in prenatal diagnosis: cytogenetic analysis in amniocytes fails to detect mosa...
21423286 - Population-specific quantitative trait loci mapping for functional stay-green trait in ...
10938546 - A new assay for the genetic study of general anesthesia in drosophila melanogaster: use...
138496 - Down syndrome due to partial trisomy 21q.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-25
Journal Detail:
Title:  Clinical chemistry     Volume:  -     ISSN:  1530-8561     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421549     Medline TA:  Clin Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Verinata Health, Inc., San Carlos, CA;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Copy-number variations in EYS: a significant event in the appearance of arRP.
Next Document:  Biological Variation and Reference Change Value of High-Sensitivity Troponin T in Healthy Individual...